Autolus Therapeutics plc Files S-1

TL;DR

Autolus Therapeutics just filed an S-1, get ready for a potential stock event.

AI Summary

Autolus Therapeutics plc filed an S-1 registration statement on May 8, 2025, for an unspecified offering. The company, incorporated in England and Wales, is based in London and operates in the biological products sector. This filing indicates a potential upcoming event for the company, such as a stock offering or other securities-related transaction.

Why It Matters

This S-1 filing signals a potential new offering or significant corporate event for Autolus Therapeutics, which could impact its stock and the biotechnology sector.

Risk Assessment

Risk Level: medium — S-1 filings are standard for public offerings but can precede significant stock price movements based on the offering details and market reception.

Key Players & Entities

• Autolus Therapeutics plc (company) — Registrant
• May 8, 2025 (date) — Filing Date
• England and Wales (jurisdiction) — Place of Incorporation
• London (location) — Principal Executive Offices
• Autolus Inc. (company) — Agent for Service

FAQ

From the Filing

0001193125-25-116059.txt : 20250508 0001193125-25-116059.hdr.sgml : 20250508 20250508170827 ACCESSION NUMBER: 0001193125-25-116059 CONFORMED SUBMISSION TYPE: S-1 PUBLIC DOCUMENT COUNT: 6 FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Autolus Therapeutics plc CENTRAL INDEX KEY: 0001730463 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1 SEC ACT: 1933 Act SEC FILE NUMBER: 333-287097 FILM NUMBER: 25927308 BUSINESS ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP BUSINESS PHONE: 44 20 3829 6230 MAIL ADDRESS: STREET 1: THE MEDIAWORKS STREET 2: 191 WOOD LANE CITY: LONDON STATE: X0 ZIP: W12 7FP FORMER COMPANY: FORMER CONFORMED NAME: Autolus Therapeutics Ltd DATE OF NAME CHANGE: 20180205 S-1 1 d938913ds1.htm S-1 S-1 Table of Contents As filed with the Securities and Exchange Commission on May 8, 2025 Registration No. 333-      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Autolus Therapeutics plc (Exact name of registrant as specified in its charter) Not Applicable (Translation of registrant’s name into English) England and Wales Not Applicable (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification Number) The MediaWorks 191 Wood Lane White City London W12 7FP United Kingdom Tel: +44 20 3829 6230 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Autolus Inc. 15810 Gaither Drive Gaithersburg, Maryland 20877 Tel: +1 240 801 3830 United States of America (Name, address and telephone number of agent for service) Copies of all communications, including communications sent to agent for service, should be sent to: Christian E. Plaza Courtney T. Thorne William DuVal Cooley LLP One Freedom Square, Reston Town Center Reston, Virginia 20190-5640 +1 703 456 8000 Claire Keast-Butler Cooley (UK) LLP 22 Bishopsgate London EC2N 4BQ United Kingdom +44 20 7583 4055 APPROXIMATE DATE OF COMMENCEMENT OF PROPOSED SALE TO THE PUBLIC : From time to time after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☒ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☒ Smaller reporting company ☒ Emerging growth company ☐ If an emerging